Current low-level SARS-CoV-2 circulation, with global test positivity rates around 1.7–3.4% and only modest case increases reported to WHO through July 2026, underpins the 96.2% market-implied probability against a new coronavirus pandemic this year. Official surveillance from CDC and WHO shows ongoing seasonal fluctuations driven by variants under monitoring such as XFG and NB.1.8.1, none of which demonstrate enhanced virulence or immune escape sufficient to overwhelm population immunity from prior infections and vaccination. No high-risk novel strains or animal-reservoir spillovers have emerged. A realistic shift could occur only if a divergent variant with substantial fitness gains appears before year-end and triggers sustained exponential growth beyond historical seasonal peaks, though current model consensus and genomic data make this unlikely.